[[Translated article]]Drug Survival in Cyclosporine Treatment for Moderate to Severe Atopic Dermatitis: Analysis of the Spanish Atopic Dermatitis Registry (BIOBADATOP)

CONCLUSIONS: Drug survival of cyclosporine in the BIOBADATOP registry is similar to that described in other series of patients with AD and longer than that observed in the BIOBADADERM psoriasis registry.PMID:38325545 | DOI:10.1016/j.ad.2023.07.028
Source: Actas Dermo-Sifiliograficas - Category: Dermatology Authors: Source Type: research